KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Medtronic (MDT) Return on Equity (2016 - 2026)

Medtronic's Return on Equity history spans 12 years, with the latest figure at 0.09% for Q1 2026.

  • For Q1 2026, Return on Equity rose 1.0% year-over-year to 0.09%; the TTM value through Jan 2026 reached 0.09%, up 1.0%, while the annual FY2024 figure was 0.07%, 0.0% changed from the prior year.
  • Return on Equity for Q1 2026 was 0.09% at Medtronic, down from 0.1% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.1% in Q3 2022 and bottomed at 0.07% in Q3 2023.
  • The 5-year median for Return on Equity is 0.08% (2024), against an average of 0.08%.
  • The largest annual shift saw Return on Equity increased 2bps in 2022 before it dropped -3bps in 2023.
  • A 5-year view of Return on Equity shows it stood at 0.08% in 2022, then decreased by -3bps to 0.08% in 2023, then rose by 11bps to 0.09% in 2024, then grew by 11bps to 0.1% in 2025, then decreased by -4bps to 0.09% in 2026.
  • Per Business Quant, the three most recent readings for MDT's Return on Equity are 0.09% (Q1 2026), 0.1% (Q4 2025), and 0.09% (Q1 2025).